Journal article · 2026 · Open access

PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES

Raheleh Masoudi, Rania Faouzi Zaarour

International Journal For Research In Biology & Pharmacy · Published 28 August 2026

Open PDFView at the publisherCite this paper

In brief

“PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES” is a 2026 journal article by Raheleh Masoudi and Rania Faouzi Zaarour, published in International Journal For Research In Biology & Pharmacy. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at International Journal For Research In Biology & Pharmacy.

Citations
0
References
29
Authors
2

Abstract

Pharmacogenomics has emerged as a key component of precision medicine by explaining how genetic variation contributes to differences in drug response, therapeutic efficacy, and susceptibility to adverse effects. Variability in drug-metabolizing enzymes, transporters, molecular targets, and signaling pathways can influence both pharmacokinetic and pharmacodynamic outcomes. This comprehensive review aimed to synthesize current evidence on the molecular and genetic determinants of drug response and toxicity and to examine their application in pharmacogenomics-guided precision medicine and personalized therapeutic strategies. Relevant peer-reviewed literature was identified through major scientific databases using terms related to pharmacogenomics, precision medicine, genetic variation, drug metabolism, drug transport, adverse drug reactions, and personalized therapy. The selected studies were organized into major thematic areas covering molecular mechanisms, toxicity, clinical applications, genomic technologies, implementation, and future directions. The reviewed evidence showed that genetic variation can alter drug metabolism, transport, target sensitivity, and toxicity risk. Pharmacogenomics-guided strategies have potential applications in oncology, cardiovascular medicine, psychiatry, infectious diseases, and other therapeutic areas. Genomic technologies and biomarker-based approaches are increasingly supporting individualized drug and dose selection, although challenges remain in population diversity, variant interpretation, clinical validation, accessibility, and routine implementation. Pharmacogenomics provides a strong molecular foundation for improving treatment efficacy and safety. Continued clinical validation and integration with broader biological and clinical information are essential for advancing personalized pharmacotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Masoudi, R., & Zaarour, R. F. (2026). PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES. International Journal For Research In Biology & Pharmacy. https://ijrbp.com/index.php/bp/article/view/2531

MLA 9

Masoudi, Raheleh, and Rania Faouzi Zaarour. “PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES.” International Journal For Research In Biology & Pharmacy, 2026. https://ijrbp.com/index.php/bp/article/view/2531.

Chicago

Masoudi, Raheleh and Rania Faouzi Zaarour. 2026. “PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES.” International Journal For Research In Biology & Pharmacy. https://ijrbp.com/index.php/bp/article/view/2531.

Harvard

Masoudi, R. and Zaarour, R. F. (2026) ‘PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES’, International Journal For Research In Biology & Pharmacy. Available at: https://ijrbp.com/index.php/bp/article/view/2531.

IEEE

R. Masoudi and R. F. Zaarour, “PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES,” International Journal For Research In Biology & Pharmacy, 2026.

BibTeX

@article{masoudi2026pharmacogenomics,
  title     = {{PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES}},
  author    = {Masoudi, Raheleh and Zaarour, Rania Faouzi},
  journal   = {International Journal For Research In Biology \& Pharmacy},
  year      = {2026},
  url       = {https://ijrbp.com/index.php/bp/article/view/2531}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • precision medicine
  • drug response
  • drug toxicity
  • adverse drug reactions
  • genetic variation
  • drug-metabolizing enzymes
  • drug transporters

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Masoudi, R., & Zaarour, R. F. (2026). PHARMACOGENOMICS IN PRECISION MEDICINE: MOLECULAR DETERMINANTS OF DRUG RESPONSE, TOXICITY, AND PERSONALIZED THERAPEUTIC STRATEGIES. International Journal For Research In Biology & Pharmacy. https://ijrbp.com/index.php/bp/article/view/2531

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal For Research In Biology & Pharmacy: sign in and open the PDF from this page.

Who wrote this paper?

Raheleh Masoudi, Rania Faouzi Zaarour.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.